Business Description
Insmed Inc
NAICS : 325412
SIC : 2834
ISIN : US4576693075
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.02 | |||||
Equity-to-Asset | 0.02 | |||||
Debt-to-Equity | 31.36 | |||||
Debt-to-EBITDA | -1.72 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.78 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.9 | |||||
3-Year EBITDA Growth Rate | -22.4 | |||||
3-Year EPS without NRI Growth Rate | -21.5 | |||||
3-Year FCF Growth Rate | -19.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 25.05 | |||||
Future 3-5Y Total Revenue Growth Rate | 48.25 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.95 | |||||
9-Day RSI | 59.29 | |||||
14-Day RSI | 56.28 | |||||
6-1 Month Momentum % | 186.62 | |||||
12-1 Month Momentum % | 186.28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.71 | |||||
Quick Ratio | 2.53 | |||||
Cash Ratio | 2.38 | |||||
Days Inventory | 408.35 | |||||
Days Sales Outstanding | 41.14 | |||||
Days Payable | 279.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.9 | |||||
Shareholder Yield % | -0.88 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 77.61 | |||||
Operating Margin % | -195.94 | |||||
Net Margin % | -244.27 | |||||
FCF Margin % | -179.73 | |||||
ROA % | -56.82 | |||||
ROIC % | -116.57 | |||||
ROC (Joel Greenblatt) % | -686.37 | |||||
ROCE % | -65.62 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 33.52 | |||||
PB Ratio | 319.91 | |||||
EV-to-EBIT | -17.73 | |||||
EV-to-Forward-EBIT | -20.5 | |||||
EV-to-EBITDA | -18.01 | |||||
EV-to-Forward-EBITDA | -19.98 | |||||
EV-to-Revenue | 38.89 | |||||
EV-to-Forward-Revenue | 23.85 | |||||
EV-to-FCF | -21.64 | |||||
Earnings Yield (Greenblatt) % | -5.64 | |||||
FCF Yield % | -4.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Insmed Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 328.605 | ||
EPS (TTM) ($) | -5.39 | ||
Beta | 0.85 | ||
Volatility % | 123.05 | ||
14-Day RSI | 56.28 | ||
14-Day ATR ($) | 1.850893 | ||
20-Day SMA ($) | 72.848201 | ||
12-1 Month Momentum % | 186.28 | ||
52-Week Range ($) | 21.96 - 80.048 | ||
Shares Outstanding (Mil) | 171.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Insmed Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Insmed Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Insmed Inc Frequently Asked Questions
What is Insmed Inc(LTS:0JAV)'s stock price today?
When is next earnings date of Insmed Inc(LTS:0JAV)?
Does Insmed Inc(LTS:0JAV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |